comparemela.com

Latest Breaking News On - Grifols group - Page 1 : comparemela.com

Biotest increased sales by 83 6% to Euro 215 2 million in first quarter 2024

EQS-News: Biotest AG / Key word: Quarter Results Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024 07.05.2024 / 09:00 CET/CEST The issuer is.

Czech republicComunidad autonoma de catalunaUnited statesUnited kingdomMonika baumann buttkereitDirk neumGrifols groupDrug administrationBiotest groupBiotest next levelBiologics license applicationPrimary immunodeficienciesBiotest nextQuarterly reportsPrime standardMonika baumann

Biotest AG increased sales by 32% in the financial year 2023

EQS-News: Biotest AG / Key word: Annual Results Biotest AG increased sales by 32% in the financial year 2023 28.03.2024 / 12:38 CET/CEST The issuer is solely.

Comunidad autonoma de catalunaUnited statesMonika baumann buttkereitDirk neumGrifols groupBiotest groupDrug administrationBiotest next levelBiologics license applicationPre license inspectionPrime standardMonika baumann

EQS-News: Biotest achieves EBIT forecast for 2023

EQS-News: Biotest AG / Key word(s): Preliminary Results Biotest achieves EBIT forecast for 2023 29.02.2024 / 07:45 CE.

Comunidad autonoma de catalunaDirk neumMonika buttkereitBiotest groupGrifols groupAnnual general meetingManagement boardSupervisory boardPrime standard

Biotest achieves EBIT forecast for 2023

EQS-News: Biotest AG / Key word: Preliminary Results Biotest achieves EBIT forecast for 2023 29.02.2024 / 07:45 CET/CEST The issuer is solely responsible for the.

Comunidad autonoma de catalunaDirk neumMonika buttkereitGrifols groupBiotest groupAnnual general meetingManagement boardSupervisory boardPrime standard

Grifols announces positive topline phase 3 fibrinogen clinical trial results

In the AdFIrst study, Biotest s fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired.

Comunidad autonoma de catalunaUnited statesIg yimmugoVictor grifols deuBiotest adfirstMedia press officeGrifols groupInvestors relations department sustainabilitySpanish stock exchangeGrifols chief scientific innovationGrifols chief operatingAdjusted fibrinogen replacement strategyNorth americaMiddle eastMercado continuoRoyal legislative decree

vimarsana © 2020. All Rights Reserved.